U.S. Markets closed

CytRx Corporation Discusses Near Term Value from Out-License Deals and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com

LOS ANGELES, CA / ACCESSWIRE / June 27, 2019 / StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Eric L. Curtis, President and COO of CytRx Corporation (CYTR), a biopharmaceutical research and development company with expertise in discovering and developing new therapeutics to treat patients with high unmet needs , according to the company's website (see here: www.cytrx.com). The video interview was recorded at SNN's studio in Los Angeles on Tuesday, May 28, 2019.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

CytRx Corporation - Biopharmaceutical Company Discusses Near Term Value from Out-License Deals and Growth Drivers for 2019

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About CytRx Corporation

CytRx Corporation (CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics to treat patients with high unmet needs. CytRx's most advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been out-licensed to NantCell, Inc. In addition, CytRx's other drug candidate, arimoclomol, has been out-licensed to Orphazyme A/S (Nasdaq Copenhagen exchange: ORPHA). Orphazyme is testing arimoclomol in four indications including amyotrophic lateral sclerosis (ALS), Niemann-Pick disease Type C (NPC), Gaucher disease and sporadic Inclusion Body Myositis (sIBM). CytRx Corporation's website is www.cytrx.com

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.

Contact:

StockNewsNow.com

info@snnwire.com

SOURCE: Stock News Now



View source version on accesswire.com:
https://www.accesswire.com/550086/CytRx-Corporation-Discusses-Near-Term-Value-from-Out-License-Deals-and-Growth-Drivers-for-2019-in-New-SNNLive-Video-Interview-on-StockNewsNowcom